Glial Fibrillary Acidic Protein (GFAP) Monoclonal Antibody - PA6633

Glial Fibrillary Acidic Protein (GFAP) Monoclonal Antibody

Sizes: 100μL, 200μL

Catalogue Numbers: PA6633-100, PA6633-200

Citations, Manuals and MSDS Available upon request.

Abbreviation: Glial Fibrillary Acidic Protein(GFAP)

Target Synonym: wu:fb34h11, ALXDRD, cb345, etID36982.3, FLJ42474, FLJ45472, GFAP, GFAP, gfapl, Glial fibrillary acidic protein, Intermediate filament protein, wu:fk42c12, xx:af506734, zgc:110485

Conjugation: Unconjugated

Host: Mouse

Species Reactivity: Human

Application: IHC-P

Clonality: Monoclonal

Clone No.: YN00866m

UNIProt ID: P14136

Background: Glial Fibrillary Acidic Protein(GFAP) is a kind of intermediate silk protein with a molecular weight of about 50 kDa. In the central nervous system, GFAP is expressed in astrocytes and ependymal cells, but not in other glial cells. However, it may be expressed in some immature oligodendrocytes and choroid plexus cells. GFAP is also expressed in Schwann cells and satellite cells of sensory ganglia in peripheral nervous system, and in myoepithelial cells and chondrocytes. In tumor tissue, GFAP is expressed in astrocytoma, ependymoma, malignant glioma, oligodendrocytoma and Schwann cell tumor. In most cases, chondroma, chondrosarcoma and pleomorphic adenoma also showed GFAP positive. This marker is mainly used to judge glioma and metastasis.

The concentrated should be stored at -20°C protecting from light,The RTU should be stored at 2~8°C protecting from light (Do not freeze).Valid for 12 months.

Shipping: Ice bag

Research Use Only